Antibody treatment which activates the patient's own immune system against cancer, known as immunotherapy, is increasingly ...

A team of scientists is investigating a new type of antibody, which stimulates the immune system to target cancer cells an ...

The relationship between food allergies and chronic illness represents one of the most significant yet underappreciated ...

Discover a study that compared the effectiveness of P043 versus omalizumab in managing uncontrolled allergic asthma.

Omlyclo is used for the treatment of moderate to severe persistent asthma, chronic rhinosinusitis with nasal polyps, ...

The overproduction of immunoglobulin E (IgE) resulting from alterations in the humoral immune response contributes to the development of allergic and atopic diseases such as allergic asthma and ...

Celltrion’s Omlyclo is interchangeable with Xolair to treat the same conditions: asthma, chronic rhinosinusitis, food allergy ...

Co., Ltd. (referred to as "Longbio"), a leading biotech company dedicated to developing innovative biologic treatments for allergy, respiratory, dermatology, hematology, ophthalmology, and other ...

SAN DIEGO -- Common triggers for food protein-induced enterocolitis syndrome (FPIES) have shifted, and more cases than ...

A new type of antibody which stimulates the immune system to target cancer cells slows tumour growth, according to new research.

On Friday, the US Food and Drug Administration (FDA) approved as the first interchangeable biosimilar to Swiss pharma giant ...